“Wild type” GIST: Clinicopathological features and clinical practice

Transcriptome sequencing identifiesETV6-NTRK3as a gene fusion involved in GIST

(2016) Monica Brenca et al.   JOURNAL OF PATHOLOGY

Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases

(2016) Jerzy Lasota et al.   MODERN PATHOLOGY

KIT, PDGFRA, and BRAF Mutational Spectrum Impacts on the Natural History of Imatinib-naive Localized GIST

(2015) Sabrina Rossi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Classification ofKIT/PDGFRAwild-type gastrointestinal stromal tumors: implications for therapy

(2015) Sebastian Huss et al.   Expert Review of Anticancer Therapy

A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors

(2015) Mai Isosaka et al.   PLoS One

PDL1 expression is an independent prognostic factor in localized GIST

(2015) François Bertucci et al.   OncoImmunology

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance

(2014) N. Javidi-Sharifi et al.   CANCER RESEARCH

Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad

(2014) Florian Haller et al.   ENDOCRINE-RELATED CANCER

Recurrent epimutation of SDHC in gastrointestinal stromal tumors

(2014) J. K. Killian et al.   Science Translational Medicine

miR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor

(2014) Sheng Liu et al.   TUMOR BIOLOGY

Immunohistochemical Loss of Succinate Dehydrogenase Subunit A (SDHA) in Gastrointestinal Stromal Tumors (GISTs) Signals SDHA Germline Mutation

(2013) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Submucosal tumors: Comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors

(2013) Toshirou Nishida et al.   Digestive Endoscopy

An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST)

(2013) Margherita Nannini et al.   JOURNAL OF MEDICAL GENETICS

Gastrointestinal stromal tumour

(2013) Heikki Joensuu et al.   LANCET

A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)

(2013) Sebastian Huss et al.   MODERN PATHOLOGY

Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors

(2012) Trisha Dwight et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

(2012) C. Miranda et al.   CLINICAL CANCER RESEARCH

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors

(2010) José Gaal et al.   MODERN PATHOLOGY

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

(2010) K. A. Janeway et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

BRAFMutation Status in Gastrointestinal Stromal Tumors

(2009) Isabelle Hostein et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Gastric Stromal Tumors in Carney Triad Are Different Clinically, Pathologically, and Behaviorally From Sporadic Gastric Gastrointestinal Stromal Tumors: Findings in 104 Cases

(2009) Lizhi Zhang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

(2008) Narasimhan P. Agaram et al.   GENES CHROMOSOMES & CANCER

Distinct Gene Expression–Defined Classes of Gastrointestinal Stromal Tumor

(2008) Umio Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients ≤40 years: an overview based on our case material and the literature

(2008) Abbas Agaimy et al.   LANGENBECKS ARCHIVES OF SURGERY